Contact this trialFirst, we need to learn more about you.
DPP4 Inhibitor
Sitagliptin for Type 2 Diabetes with Genetic Mutation
Recruiting2 awardsPhase 4
Philadelphia, Pennsylvania
This trial is testing whether a DPP4 inhibitor can help people with a specific gene mutation by reducing DPP4 activity and glucose levels.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service